Rabbit Monoclonal to Rhesus CXCL8
Rhesus IL-8 / Interleukin-8 / CXCL8
IL-8 antibody; Interleukin-8 antibody
This antibody was obtained from a rabbit immunized with purified, recombinant Rhesus IL-8 / Interleukin-8 / CXCL8 .
0.2 μm filtered solution in PBS
This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free.
Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.
ELISA: 0.1-0.2 μg/ml
This antibody can be used at 0.1-0.2 μg/ml with the appropriate secondary reagents to detect Rhesus IL-8 / Interleukin-8 / CXCL8.
Interleukin 8 (IL-8), also known as CXCL8, which is a chemokine with a defining CXC amino acid motif that was initially characterized for its leukocyte chemotactic activity, is now known to possess tumorigenic and proangiogenic properties as well. This chemokine is secreted by a variety of cell types including monocyte/macrophages, T cells, neutrophils, fibroblasts, endothelial cells, and various tumor cell lines in response to inflammatory stimuli (IL1, TNF, LPS, etc). In human gliomas, IL-8 is expressed and secreted at high levels both in vitro and in vivo, and recent experiments suggest it is critical to glial tumor neovascularity and progression. Levels of IL-8 correlate with histologic grade in glial neoplasms, and the most malignant form, glioblastoma, shows the highest expression in pseudopalisading cells around necrosis, suggesting that hypoxia/anoxia may stimulate expression. Interleukin (IL)-8/CXCL8 is a potent neutrophil chemotactic factor. Accumulating evidence has demonstrated that various types of cells can produce a large amount of IL-8/CXCL8 in response to a wide variety of stimuli, including proinflammatory cytokines, microbes and their products, and environmental changes such as hypoxia, reperfusion, and hyperoxia. Numerous observations have established IL-8/CXCL8 as a key mediator in neutrophil-mediated acute inflammation due to its potent actions on neutrophils. However, several lines of evidence indicate that IL-8/CXCL8 has a wide range of actions on various types of cells, including lymphocytes, monocytes, endothelial cells, and fibroblasts, besides neutrophils. The discovery of these biological functions suggests that IL-8/CXCL8 has crucial roles in various pathological conditions such as chronic inflammation and cancer. IL-8 has been associated with tumor angiogenesis, metastasis, and poor prognosis in breast cancer. IL-8 may present a novel therapeutic target for estrogen driven breast carcinogenesis and tumor progression.
Related Products / Services
- Recombinant Proteins
- cDNA Clones
- Canine IL-8/CXCL8 recombinant protein$191.1
- Human IL-8/CXCL8 (aa 23-99) recombinant protein$239.5
- Human IL-8/CXCL8 (aa 28-99) recombinant protein$130.6
- Human IL-8/CXCL8 (His Tag) recombinant protein$166.9
- Human IL-8/CXCL8 (aa 23-99, Fc Tag) recombinant protein$239.5
- Human IL-8/CXCL8 (aa 28-99, Fc Tag) recombinant protein$239.5
- Human IL-8/CXCL8 (aa 28-99) recombinant protein$239.5
- Human CXCL8/IL8 recombinant protein$275.5
- Human CXCL8/IL8 recombinant protein$285
- Human CXCL8/IL8 (His tag) recombinant protein$274.6
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"